Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections.
The clinical efficacy of oral pyronaridine was assessed in 22 symptomatic Cameroonian patients infected with Plasmodium ovale or Plasmodium malariae. All patients were cured on or before day 4. In vitro drug assays confirmed the sensitivity of P. ovale and P. malariae isolates to chloroquine and pyr...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1997
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164120/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9333075/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.10.2317 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|